TELEDYNE DALSA - BIOMEMS MANUFACTURING

Glass & silicon for BioMEMS
The heart of tomorrow’s medical devices

Online event: Glass and silicon BioMEMS components at the heart of tomorrow’s medical devices webcast - Nov. 24, 2020 - REGISTER

Extracted from: BioMEMS Market and Technology report - Status of the Microfluidics Industry report - Status of Medical Imaging Equipment and Detectors 2020, Yole Développement

OUTLINES:

  • BioMEMS industry:
    According to Yole Développement (Yole), the bioMEMS device market is expected to reach US$6.3 billion in 2025 with a 9.2% CAGR 19-25.
    MEMS foundries are developing advanced platforms providing added-value wafers and specialized processing steps.
    Overall, materials represent between 3-5% of the microfluidic device market, in value, of which 50% is using glass...
  • With its recent acquisition of Micralyne, Teledyne is a serious bioMEMS player with microfluidic chip and drug delivery solutions.
  • COVID-19 outbreak:
    After combining the positive and negative impacts, the overall bioMEMS market is expected to show a 12.4% growth from 2019 to 2020.
    The impact of COVID-19 on bioMEMS market dynamics will not be the same from one application to another.
  • Yole and Teledyne MEMS organize the “Glass and silicon bioMEMS components at the heart of tomorrow’s medical devices” webcast on Nov. 24, 2020, to highlight the role of glass and silicon bioMEMS components in medical devices along with Teledyne MEMS’ expertise in their manufacturing.
    Register on i-Micronews
  • TO DOWNLOAD THE PRESS RELEASE: ENGLISH 

“In today’s world, healthcare is more important than ever. Micro-technologies enable the production of medical devices that are needed for patient care, diagnostics, and monitoring,” states Collin Twanow, Director of Technology at Teledyne MEMS. “From neurostimulation implants and DNA sequencing chips to drug delivery devices and point-of-care tests for diagnosing COVID-19, micro-technologies are everywhere. BioMEMS materials, including glass, silicon, and polymers, are determined by their function. The Teledyne MEMS group has extensive experience with these materials.”
MEMS is a revolutionary chip-based technology that combines microelectronics with micromachining technology. The sophisticated technology involved means that they are not easy to develop and manufacture, as very specific expertise is required to make robust micro-devices suited for products that deal with human health. Teledyne’s MEMS capabilities, through Teledyne DALSA and Teledyne Micralyne, provide customers with matchless MEMS capabilities. Through years of custom MEMS wafer processing and devoted research and development, the group offers a profound understanding of the physics and materials science that make MEMS possible. Dedicated to customer success, driven by rigourous quality systems, service, and protection of intellectual property, the Teledyne MEMS group partners with its customers to offer experience to add project value.

In this context, the market research and strategy consulting company, Yole Développement (Yole) investigates disruptive micro-technologies and related markets including the medical sector.
“The bioMEMS device market is expected to reach more than US$6 billion by 2025 with a 9.2% CAGR from 2019 to 2025,” announces Sébastien Clerc, Technology & Market Analyst in Microfluidics, Sensing & Actuating at Yole.
Microfluidic chips still represent the largest part of the bioMEMS market and compete with MEMS pressure sensors when counting only silicon microfluidics. It is also worth noting that the bioMEMS device market is growing faster than the medical device market, which has about 4.5% growth year over year on the last decade, showing greater penetration of MEMS technologies compared to conventional ones.
“BioMEMS are more than ever the technology of choice, selected for high levels of integration, miniaturization and low power consumption in a transforming healthcare sector,” adds Sébastien Clerc from Yole.

Yole and Teledyne MEMS combine their knowledge and announce today the Glass and silicon BioMEMS components at the heart of tomorrow’s medical devices webcast. Taking place on November 24, this webcast is powered by the Teledyne MEMS group, organized by Yole and supported by i-Micronews.com.

For one hour, both speakers, Collin Twanow from the Teledyne MEMS group and Sebastien Clerc from Yole will give an overview of the role of micro-technologies for medical applications, the challenges related to their fabrication along with the main areas of growth. This online event is a great opportunity to get a better understanding of Teledyne MEMS’ capabilities and expertise.
Make sure to attend both presentations and take part in the Q&A session. Register today!

Acronym
CAGR: Compound Annual Growth Rate
 

###